Status: Not yet recruiting
Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC
This is a single-arm, open-label, single-center phase II trial that will enroll 30 patients with limited-stage small-cell lung cancer to evaluate the safety and efficacy of adebrelimab combined with chemoradiotherapy followed by adebrelimab maintenance.
Participants needed: 30
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Peking University Cancer Hospital & InstituteUpdated: Sep 30, 2025Locations: 1
Eligibility criteria
Age 18-75 years, either sex. Histologically or cytologically confirmed limited-s...
Prior solid-organ, allogeneic stem-cell or planned transplantation. Immunosuppre...